| 30th Jun 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 30th Jun 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 30th Jun 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 30th Jun 2022 9:05 am |
RNS |
Second Price Monitoring Extn |
| 30th Jun 2022 9:00 am |
RNS |
Price Monitoring Extension |
| 30th Jun 2022 7:01 am |
RNS |
2021 Annual Report and 2022 AGM Notice |
| 30th Jun 2022 7:00 am |
RNS |
Business Update, Final Results&Financing Agreement |
| 29th Jun 2022 7:00 am |
RNS |
Notice of Results |
| 28th Jun 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 28th Jun 2022 4:35 pm |
RNS |
Price Monitoring Extension |
| 28th Jun 2022 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 28th Jun 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 29th Apr 2022 7:00 am |
RNS |
Total Voting Rights Update |
| 31st Mar 2022 3:50 pm |
RNS |
Block Listing Application |
| 31st Mar 2022 3:50 pm |
RNS |
Block Listing 6 Monthly Return |
| 21st Mar 2022 7:00 am |
RNS |
KYE Pharmaceuticals Files Accrufer® NDS in Canada |
| 2nd Mar 2022 1:30 pm |
EQS |
Hardman & Co Research: Shield Therapeutics (STX) - PBMs have bought in to Accrufer |
| 25th Feb 2022 7:00 am |
RNS |
Investor Presentation |
| 23rd Feb 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 23rd Feb 2022 2:01 pm |
RNS |
Price Monitoring Extension |
| 23rd Feb 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 23rd Feb 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 18th Feb 2022 2:06 pm |
RNS |
Second Price Monitoring Extn |
| 18th Feb 2022 2:00 pm |
RNS |
Price Monitoring Extension |
| 17th Feb 2022 9:05 am |
RNS |
Second Price Monitoring Extn |
| 17th Feb 2022 9:00 am |
RNS |
Price Monitoring Extension |
| 17th Feb 2022 7:00 am |
RNS |
Full Year Trading Update |
| 4th Feb 2022 7:00 am |
RNS |
KOL Investor Event on Iron Deficiency |
| 7th Jan 2022 7:00 am |
RNS |
Investor Presentation |
| 5th Jan 2022 7:00 am |
RNS |
Licence Agreement in Canada for Accrufer® |
| 30th Dec 2021 9:06 am |
RNS |
Second Price Monitoring Extn |
| 30th Dec 2021 9:00 am |
RNS |
Price Monitoring Extension |
| 29th Dec 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 29th Dec 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 16th Dec 2021 11:05 am |
RNS |
Second Price Monitoring Extn |
| 16th Dec 2021 11:00 am |
RNS |
Price Monitoring Extension |
| 16th Dec 2021 7:00 am |
RNS |
Patient Access Expands for Accrufer® |
| 7th Oct 2021 9:45 am |
EQS |
Hardman & Co Research: Shield Therapeutics (STX) Life Sciences Investor Forum research |
| 30th Sep 2021 5:30 pm |
RNS |
Block Listing 6 Monthly Return |
| 27th Sep 2021 7:00 am |
RNS |
Jose A. Menoyo Appointed as Chief Medical Officer |
